SENSHIO

This brand name is authorized in Austria, Estonia, Spain, Croatia, Ireland, Italy, Lithuania, Poland, Singapore, United Kingdom

Active ingredients

The drug SENSHIO contains one active pharmaceutical ingredient (API):

1 Ospemifene UNII B0P231ILBK - OSPEMIFENE

Ospemifene and its major metabolite have an oestrogen like effect in the vagina increasing the cellular maturation and mucification of the vaginal epithelium. Ospemifene’s biological actions are mediated through the binding of ospemifene and its major metabolite to oestrogen receptors leading to activation of some oestrogenic pathways (agonism) and blockade of other (antagonism). Read about Ospemifene

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SENSHIO Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03XC05		G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03X Other sex hormones and modulators of the genital system → G03XC Selective estrogen receptor modulators
Discover more medicines within G03XC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1676178, 1676189, 1766190
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114978002
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 357248
Country: IT	Agenzia del Farmaco	Identifier(s): 043868013, 043868025, 043868037
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1075826, 1075827, 1084613
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100338167
Country: SG	Health Sciences Authority	Identifier(s): 15568P